𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Visceral leishmaniasis complicating chronic hepatitis B treated with interferon

✍ Scribed by Giovanna Fattovich; G. Giustina; F. Adami


Publisher
Springer-Verlag
Year
1992
Tongue
English
Weight
231 KB
Volume
20
Category
Article
ISSN
0300-8126

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


Relevance of inapparent coinfection by h
✍ Zignego, Anna Linda; Fontana, Rossana; Puliti, Silvia; Barbagli, Susanna; Monti, πŸ“‚ Article πŸ“… 1997 πŸ› John Wiley and Sons 🌐 English βš– 191 KB πŸ‘ 2 views

The aim of the study was to investigate whether an ''inapparent'' coinfection by hepatitis B virus (HBV) in anti-HCV-positive chronic liver disease patients may influence interferon (IFN) response. Fourteen anti-HCV-positive, hepatitis B surface antigen (HBsAg)-negative but serum HBV-DNA-positive pa

Levamisole and interferon in children wi
✍ Mercedes Ruiz-Moreno; Rosa GarcΓ­a; Maria Jose Rua; Beatriz Serrano; Gloria Moral πŸ“‚ Article πŸ“… 1993 πŸ› John Wiley and Sons 🌐 English βš– 531 KB

To evaluate the possible usefulness of simultaneous administration of levamisole and interferon, we randomly allocated 38 children with chronic hepatitis B to receive either 10 MU/m2 interferon-a-2a, three times a week for 6 mo (group 1, n = 20) or 90 mg/m" of levamisole for 45 days, together with 1

Changes in interferon receptors on perip
✍ Dr. Shinya Nakajima; Tetsuo Kuroki; Machiko Shintani; Osamu Kurai; Tadashi Taked πŸ“‚ Article πŸ“… 1990 πŸ› John Wiley and Sons 🌐 English βš– 407 KB πŸ‘ 1 views

We studied the binding of ""I-labeled human interferon-a to peripheral blood mononuclear cells and the activity of 2',5'-oligoadenylate synthetase in peripheral blood mononuclear cells obtained from 2 l patients with chronic hepatitis B who were treated with human interferon-a or interferon+. Fourte

Interferon and chronic non-A, non-B hepa
✍ Harold O. Conn; Ronald L. Koretz πŸ“‚ Article πŸ“… 1990 πŸ› John Wiley and Sons 🌐 English βš– 351 KB πŸ‘ 1 views

Chronic hepatitis C (non-A, non-B hepatitis) is a common and often progressive viral liver diseeee. To aegees the efficacy of therapy with the antiviral agent interferon alfa, we randomly assigned 166 patients with chronic hepatitis C to treatment with either 3 million or 1 million units of recombin

HCV RNA in patients with chronic hepatit
✍ T. Jake Liang; Vinod Rustgi; Eithan Galun; Hubert E. Blum πŸ“‚ Article πŸ“… 1993 πŸ› John Wiley and Sons 🌐 English βš– 954 KB

## Abstract In order to assess the efficacy of interferon‐α on hepatitis C viral RNA in patients with chronic hepatitis C, we analyzed the levels of HCV RNA in sera and liver tissues of 16 patients pre‐ and posttreatment using a semiquantitative polymerase chain reaction method. Fifteen of 16 patie